BMC CANCER 润色咨询

BMC CANCER

出版年份:2001 年文章数:12290 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:1.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-07-23 ms9000001935138113 来自北京

    偏重的研究方向:肿瘤
    经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2024-01-23 ms5000000169069735 来自北京

    peer review两个月了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2024-01-19 硅星 来自北京

    各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-04-23 1479422cm92暂无昵称 来自青海省

    纯生信的文章不知道是不是接受

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2024-01-11 ms4000001896463781 来自北京

    偏重的研究方向:肿瘤
    经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-04-06 YG社长候选人 来自四川省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:影像组学;乳腺癌;病理组学
    经验分享:
    Submission accepted
    06 Apr 2023
    Submission under peer review
    23 Mar 2023
    Submission passed technical check
    23 Mar 2023
    Amendment received
    23 Mar 2023
    Revision received
    23 Mar 2023
    Submission under peer review
    01 Mar 2023
    Technical check
    Submission passed technical check
    01 Mar 2023
    Amendment received
    25 Feb 2023
    Amendment received
    22 Feb 2023
    Submission is under technical check
    15 Feb 2023
    Submission received
    15 Feb 2023
    刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。

    7

    展开7条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-12-06 ms9000000228172903 来自甘肃省

    外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭,

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-12-31 lili689797 来自四川省

    审稿速度:2.0
    经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-11-27 luoluojian 来自广东省

    请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向:肿瘤<br>经验分享:请问各位大佬,大家的editor invited持续了多久? editor invited之后的状态就是编辑评估后送外审了吧?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2183449, encodeId=4b6c2183449d7, content=peer review两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8f388241074, createdName=ms5000000169069735, createdTime=Tue Jan 23 15:16:26 CST 2024, time=2024-01-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬,请问这个杂志的质控过程一般持续多久啊,已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向:肿瘤<br>经验分享:请问下大家,纯生信文章还能投这本吗,孩子急着毕业,真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:影像组学;乳腺癌;病理组学<br>经验分享:<br>Submission accepted<br>06 Apr 2023<br>Submission under peer review<br>23 Mar 2023<br>Submission passed technical check<br>23 Mar 2023<br>Amendment received<br>23 Mar 2023<br>Revision received<br>23 Mar 2023<br>Submission under peer review<br>01 Mar 2023<br>Technical check<br>Submission passed technical check<br>01 Mar 2023<br>Amendment received<br>25 Feb 2023<br>Amendment received<br>22 Feb 2023<br>Submission is under technical check<br>15 Feb 2023<br>Submission received<br>15 Feb 2023<br>刚开始投的时候看了论坛也比较忐忑,但其实时间也很快,不到两个月就接受了 同行评审只用了10天左右,以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了,这是不是GG了,/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2178388, encodeId=06fa21e83886a, content=审稿速度:2.0<br>经验分享:10.26投稿;11.17返修;12.18修回(临床工作太忙实在没时间,一个月才修回去);12.27接收。做的是病毒性肿瘤,生信+简单的PCR验证,这个属于灵光一现想法发的小论文。感觉更看巧思吧,同时投稿的另外一篇套路性文章,到现在都没编辑接手。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/SiaIEyKuJeHqicXxCYXZFbFetYEFfYko4jsZRicgkriaMmz8tm0CeMqPR5FwMCnb1lnQlYsqrgY51axEUQT6yDuQvA/132, createdBy=4e062497452, createdName=lili689797, createdTime=Sun Dec 31 22:48:27 CST 2023, time=2023-12-31, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2171272, encodeId=766321e127207, content=请问大家有没有遇到过文章接收后,交了版面费,一直等不到校稿,流程提示2周后校稿,结果3个月了都没收到任何信息,发了邮件问也没回,这是什么情况?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:42:48 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2171273, encodeId=28fc21e1273de, content=审稿速度:12.0 | 投稿命中率:75.0<br>经验分享:投稿7个月给回复,第8个月接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76425513580, createdName=luoluojian, createdTime=Mon Nov 27 14:44:34 CST 2023, time=2023-11-27, status=1, ipAttribution=广东省)]
    2023-11-27 luoluojian 来自广东省

    审稿速度:12.0 | 投稿命中率:75.0
    经验分享:投稿7个月给回复,第8个月接受。

    0

共500条页码: 2/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分